BioMed Leaders KRBP, NMLSF, VERU, AIMLF Report Latest Advances in Vaccines, Novel Therapeutics for Oncology, and Autism and HealthTech AI
Summary by Ground News
Wall Street Reporter highlights the latest comments from industry thought leaders shaping our world today, and in the decades ahead. Kiromic BioPharma (NASDAQ: KRBP) CEO Pietro Bersani: Gamma Delta T cell Pipeline Expanding to Five. AI/ML Innovations (OTC: AIMLF) Chairman, Tim Daniels: AI/ML Holds Key Patents for Multi-Billion Dollar Healthcare Wearables Market.4 months ago
News Articles
More Filters
All
Left
Center
Right
Similar News Topics
Time & Location
Sources are mostly out of (0)
Bias Distribution
No sources with tracked biases.
C 100%
See less detail
